These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 20148714)
1. Autoimmune diseases: MIF as a therapeutic target. Greven D; Leng L; Bucala R Expert Opin Ther Targets; 2010 Mar; 14(3):253-64. PubMed ID: 20148714 [TBL] [Abstract][Full Text] [Related]
2. MIF in autoimmunity and novel therapeutic approaches. Stosic-Grujicic S; Stojanovic I; Nicoletti F Autoimmun Rev; 2009 Jan; 8(3):244-9. PubMed ID: 18721909 [TBL] [Abstract][Full Text] [Related]
3. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Flaster H; Bernhagen J; Calandra T; Bucala R Mol Endocrinol; 2007 Jun; 21(6):1267-80. PubMed ID: 17389748 [TBL] [Abstract][Full Text] [Related]
4. Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders. Cvetkovic I; Stosic-Grujicic S Int Immunopharmacol; 2006 Oct; 6(10):1527-34. PubMed ID: 16919824 [TBL] [Abstract][Full Text] [Related]
5. New therapeutic target in inflammatory disease: macrophage migration inhibitory factor. Morand EF Intern Med J; 2005 Jul; 35(7):419-26. PubMed ID: 15958113 [TBL] [Abstract][Full Text] [Related]
6. Current developments of macrophage migration inhibitory factor (MIF) inhibitors. Xu L; Li Y; Sun H; Zhen X; Qiao C; Tian S; Hou T Drug Discov Today; 2013 Jun; 18(11-12):592-600. PubMed ID: 23466524 [TBL] [Abstract][Full Text] [Related]
7. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Morand EF; Leech M; Bernhagen J Nat Rev Drug Discov; 2006 May; 5(5):399-410. PubMed ID: 16628200 [TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus. Bilsborrow JB; Doherty E; Tilstam PV; Bucala R Expert Opin Ther Targets; 2019 Sep; 23(9):733-744. PubMed ID: 31414920 [No Abstract] [Full Text] [Related]
9. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Renner P; Roger T; Calandra T Clin Infect Dis; 2005 Nov; 41 Suppl 7():S513-9. PubMed ID: 16237655 [TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor and its role in autoimmune diseases. Denkinger CM; Metz C; Fingerle-Rowson G; Denkinger MD; Forsthuber T Arch Immunol Ther Exp (Warsz); 2004; 52(6):389-400. PubMed ID: 15577740 [TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases. Hoi AY; Iskander MN; Morand EF Inflamm Allergy Drug Targets; 2007 Sep; 6(3):183-90. PubMed ID: 17897055 [TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor and glucocorticoid sensitivity. Aeberli D; Leech M; Morand EF Rheumatology (Oxford); 2006 Aug; 45(8):937-43. PubMed ID: 16705047 [TBL] [Abstract][Full Text] [Related]
14. Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential. Bloom J; Metz C; Nalawade S; Casabar J; Cheng KF; He M; Sherry B; Coleman T; Forsthuber T; Al-Abed Y J Biol Chem; 2016 Dec; 291(51):26502-26514. PubMed ID: 27793992 [TBL] [Abstract][Full Text] [Related]
15. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113 [TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis. Nicoletti F; Créange A; Orlikowski D; Bolgert F; Mangano K; Metz C; Di Marco R; Al Abed Y J Neuroimmunol; 2005 Nov; 168(1-2):168-74. PubMed ID: 16171874 [TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock. Calandra T; Bucala R J Inflamm; 1995-1996; 47(1-2):39-51. PubMed ID: 8913928 [TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus. Sanchez-Zamora Y; Terrazas LI; Vilches-Flores A; Leal E; Juárez I; Whitacre C; Kithcart A; Pruitt J; Sielecki T; Satoskar AR; Rodriguez-Sosa M FASEB J; 2010 Jul; 24(7):2583-90. PubMed ID: 20203087 [TBL] [Abstract][Full Text] [Related]
19. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269 [TBL] [Abstract][Full Text] [Related]
20. The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis. Santos LL; Morand EF Wien Med Wochenschr; 2006 Jan; 156(1-2):11-8. PubMed ID: 16465610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]